Atomoxetine versus stimulants in the community treatment of children with ADHD: An electronic diary study

Journal of Attention Disorders

Volumn 13, Issue 4, 2010, Pages 391-400

  Whalen, Carol K ^a   Henker, Barbara ^b   Ishikawa, Sharon S ^a   Emmerson, Natasha A ^a   Swindle, Ralph ^c   Johnston, Joseph A ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c ELI LILLY AND COMPANY   (United States)

Author keywords

ADHD; Atomoxetine; Electronic diaries; Stimulants

Indexed keywords

ATOMOXETINE; CENTRAL STIMULANT AGENT; PROPYLAMINE;

ARTICLE; ATTENTION DEFICIT DISORDER; BEHAVIOR DISORDER; CHILD; CHILD BEHAVIOR; CHILD PARENT RELATION; COMPARATIVE STUDY; DRUG ADMINISTRATION; FEMALE; HUMAN; MALE; MICROCOMPUTER; MOTHER; MOTHER CHILD RELATION; PATIENT COMPLIANCE; QUESTIONNAIRE;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; CHILD BEHAVIOR; CHILD BEHAVIOR DISORDERS; COMPUTERS, HANDHELD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MOTHER-CHILD RELATIONS; MOTHERS; PARENTING; PATIENT COMPLIANCE; PROPYLAMINES; QUESTIONNAIRES;

EID: 72149133369     PISSN: 10870547     EISSN: 15571246     Source Type: Journal    
DOI: 10.1177/1087054708325118     Document Type: Article

References (35)

1. Achenbach, T.M. (2006). As others see us: Clinical and research implications of cross-informant correlations for psychopathology. Current Directions in Psychological Science, 15, 94-98.
2. Banaschewski, T., Coghill, D., Santosh, P., Zuddas, A., Asherson, P., Buitelaar, J.,et al.(2006). Long-acting medications for the hyper-kinetic disorders. A systematic review and European treatment guideline. European Child and Adolescent Psychiatry, 15, 476-495.
3. Barbaresi, W.J., Katusic, S.K., Colligan, R.C., Weaver, A.L., Leibson, C.L., & Jacobsen, S.J. (2006). Long-term stimulant medication treatment of attention-deficit/hyperactivity disorder: Results from a population-based study. Journal of Developmental and Behavioral Pediatrics, 27, 1-10.
4. Biederman, J., Gao, H., Rogers, A.K., & Spencer, T.J. (2006). Comparison of parent and teacher reports of attention-deficit/ hyperactivity disorder symptoms from two placebo-controlled studies of atomoxetine in children. Biological Psychiatry, 60, 1106-1110.
5. Buhrmester, D., Camparo, L., Christensen, A., Gonzalez, L.S., & Hinshaw, S.P. (1992). Mothers and fathers interacting in dyads and triads with normal and hyperactive sons. Developmental Psychology, 28, 500-509.
6. Centers for Disease Control and Prevention. (2005). Prevalence of diagnosis and medication treatment for attention-deficit/hyperactivity disorder-United States, 2003. Morbidity and Mortality Weekly Report, 54, 842-847.
7. Dale, O., & Hagen, K.B. (2007). Despite technical problems personal digital assistants outperform pen and paper when collecting patient diary data. Journal of Clinical Epidemiology, 60, 8-17.
8. De Los Reyes, A., & Kazdin, A.E. (2005). Informant discrepancies in the assessment of childhood psychopathology: A critical review, theoretical framework, and recommendations for further study. Psychological Bulletin, 131, 483-509.
9. Faraone, S.V., Biederman, J., Spencer, T.J., & Aleardi, M. (2006). Comparing the efficacy of medications for ADHD using meta-analysis. Medscape General Medicine, 8, 1-12.
10. Fontanarosa, P.B., Rennie, D., & DeAngelis, C.D. (2004). Postmarketing surveillance-lack of vigilance, lack of trust. Journal of the American Medical Association, 292, 2647-2650.
11. Froehlich, T.E., Lanphear, B.P., Epstein, J.N., Barbaresi, W.J., Katusic, S.K., & Kahn, R.S. (2007). Prevalence, recognition, and treatment of attention-deficit/hyperactivity disorder in a national sample of US children. Archives of Pediatric and Adolescent Medicine, 161, 857-864.
12. Gadeyne, E., Ghesquiere, P., & Onghena, P. (2004). Longitudinal relations between parenting and child adjustment in young children. Journal of Clinical Child & Adolescent Psychology, 33, 347-358.
13. Geller, D., Donnelly, C., Lopez, F., Rubin, R., Newcorn, J., Sutton, V.,et al.(2007). Atomoxetine treatment for pediatric patients with attention-deficit/hyperactivity disorder with comorbid anxiety disorder. Journal of the American Academy of Child & Adolescent Psychiatry, 46, 1119-1127.
14. Heil, S.H., Holmes, H.W., Bickel, W.K., Higgins, S.T., Badger, G.J., Laws, H.F.,et al.(2002). Comparison of the subjective, physiological, and psychomotor effects of atomoxetine and methylphenidate in light drug users. Drug and Alcohol Dependence, 67, 149-156.
15. Hufford, M.R., Stone, A.A., Shiffman, S., Schwartz, J.E., & Broderick, J.E. (2002). Paper vs. electronic diaries: Compliance and subject evaluations. Applied Clinical Trials, 11, 38-43.
16. Jasinski, D.R., Faries, D.E., Moore, R.J., Schuh, L.M., & Allen, A.J. (2008). Abuse liability assessment of atomoxetine in a drug-abusing population. Drug and Alcohol Dependence, 95, 140-146.
17. Johnson, J.H., & Reader, S.K. (2002). Assessing stress in families of children with ADHD: Preliminary development of the Disruptive Behavior Stress Inventory (DBSI). Journal of Clinical Psychology in Medical Settings, 9, 51-62.
18. Johnston, C., & Murray, C. (2003). Incremental validity in the psychological assessment of children and adolescents. Psychological Assessment, 15, 496-507.
19. Kaufman, J., Birmaher, B., Brent, D., Rao, U., Flynn, C., Moreci, P.,et al.(1997). Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): Initial reliability and validity data. Journal of the American Academy of Child & Adolescent Psychiatry, 36, 980-988.
20. Kelsey, D.K., Sumner, C.R., Casat, C.D., Coury, D.L., Quintana, H., Saylor, K.E.,et al.(2004). Once-daily atomoxetine treatment for children with attention-deficit/hyperactivity disorder, including an assessment of evening and morning behavior: A double-blind, placebo-controlled trial. Pediatrics, 114, e1-e8.
21. Kemner, J.E., Starr, H.L., Ciccone, P.E., Hooper-Wood, C.G., & Crockett, R.S. (2005). Outcomes of OROS methylphenidate compared with atomoxetine in children with ADHD: A multicenter, randomized prospective study. Advances in Therapy, 22, 498-512.
22. Kratochvil, C.J., Heiligenstein, J.H., Dittmann, R., Spencer, T.J., Biederman, J., Wernicke, J.,et al.(2002). Atomoxetine and methylphenidate treatment in children with ADHD: A prospective, randomized, open-label trial. Journal of the American Academy of Child & Adolescent Psychiatry, 41, 776-784.
23. Michelson, D., Allen, A.J., Busner, J., Casat, C., Dunn, D., Kratochvil, C.,et al.(2002). Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: A randomized, placebo-controlled study. American Journal of Psychiatry, 159, 1896-1901.
24. Newcorn, J., Kratochvil, C., Allen, A., Casat, C., Ruff, D., Moore, R.,et al.(2008). Atomoxetine and osmotically released methylphenidate for the treatment of attention deficit hyperactivity disorder: Acute comparison and differential response. American Journal of Psychiatry, 165, 721-730.
25. Olfson, M., Gameroff, M.J., Marcus, S.C., & Jensen, P.S. (2003). National trends in the treatment of attention deficit hyperactivity disorder. American Journal of Psychiatry, 160, 1071-1077.
26. Pliszka, S. (2007). Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. Journal of the American Academy of Child & Adolescent Psychiatry, 46, 894-921.
27. Shiffman, S., Stone, A.A., & Hufford, M.R. (2008). Ecological momentary assessment. Annual Review of Clinical Psychology, 4, 1-32.
28. Spencer, T.J., Sallee, F.R., Gilbert, D.L., Dunn, D.W., McCracken, J.T., Coffey, B.J.,et al.(2008). Atomoxetine treatment of ADHD in children with comorbid tourette syndrome. Journal of Attention Disorders, 11, 470-481.
29. Stone, A.A., Shiffman, S., Schwartz, J.E., Broderick, J.E., & Hufford, M.R. (2002). Patient non-compliance with paper diaries. British Medical Journal, 324, 1193-1194.
30. Swanson, J.M., Kraemer, H.C., Hinshaw, S.P., Arnold, L.E., Conners, C.K., Abikoff, H.B.,et al.(2001). Clinical relevance of the primary findings of the MTA: Success rates based on severity of ADHD and ODD symptoms at the end of treatment. Journal of the American Academy of Child & Adolescent Psychiatry, 40, 168-179.
31. Wang, Y., Zheng, Y., Du, Y., Song, D.H., Shin, Y.J., Cho, S.C.,et al.(2007). Atomoxetine versus methylphenidate in paediatric outpatients with attention deficit hyperactivity disorder: A randomized, double-blind comparison trial. Australian and New Zealand Journal of Psychiatry, 41, 222-230.
32. Weiss, M., Tannock, R., Kratochvil, C., Dunn, D., Velez-Borras, J., Thomason, C.,et al.(2005). A randomized, placebo-controlled study of once-daily atomoxetine in the school setting in children with ADHD. Journal of the American Academy of Child & Adolescent Psychiatry, 44, 647-655.
33. Whalen, C.K., Henker, B., Ishikawa, S.S., Jamner, L.D., Floro, J.N., Johnston, J.A.,et al.(2006). An electronic diary study of contextual triggers and ADHD: Get ready, get set, get mad. Journal of the American Academy of Child & Adolescent Psychiatry, 45, 166-174.
34. Whalen, C.K., Henker, B., Jamner, L.D., Ishikawa, S.S., Floro, J.N., Swindle, R.,et al.(2006). Toward mapping daily challenges of living with ADHD: Maternal and child perspectives using electronic diaries. Journal of Abnormal Child Psychology, 34, 115-130.
35. Wigal, S.B., McGough, J.J., McCracken, J.T., Biederman, J., Spencer, T.J., Posner, K.L.,et al.(2005). A laboratory school comparison of mixed amphetamine salts extended release (Adderall XR) and atomoxetine (Strattera) in school-aged children with attention deficit/hyperactivity disorder. Journal of Attention Disorders, 9, 275-289.